Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program
(2008) In Journal of Vascular Surgery 48(2). p.394-399- Abstract
- Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods. Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29... (More)
- Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods. Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29 (range, 11-68); 40% current or previous smoker; and 24% taking antiplatelet therapy and 4% taking warfarin. If placed in a situation conducive for VTE, 40% of participants were low risk, 22% were moderate risk, 21% were high risk, and 17% were very high risk. On a venous QOL assessment, 17% had a combined total score for all 11 questions of "very limited" or "impossible to do." Reflux or obstruction was noted in 37% and 5% of participants, respectively. CEAP class 0 to 6 was 29%, 29%, 23%, 10%, 9%, 1.5%, 0.5%, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1253646
- author
- McLafferty, Robert B. ; Passman, Marc A. ; Caprini, Joseph A. ; Rooke, Thom W. ; Markwell, Steven A. ; Lohr, Joanne M. ; Meissner, Mark H. ; Eklof, Bo G. LU ; Wakefield, Thomas W. and Dalsing, Michael C.
- organization
- publishing date
- 2008
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Vascular Surgery
- volume
- 48
- issue
- 2
- pages
- 394 - 399
- publisher
- Mosby-Elsevier
- external identifiers
-
- wos:000258035800023
- scopus:47249116467
- pmid:18572373
- ISSN
- 1097-6809
- DOI
- 10.1016/j.jvs.2008.03.041
- language
- English
- LU publication?
- yes
- id
- c80545cc-38b0-4402-95a7-c3741d0e9c07 (old id 1253646)
- date added to LUP
- 2016-04-01 13:06:20
- date last changed
- 2022-04-21 19:45:35
@article{c80545cc-38b0-4402-95a7-c3741d0e9c07,
abstract = {{Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods. Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29 (range, 11-68); 40% current or previous smoker; and 24% taking antiplatelet therapy and 4% taking warfarin. If placed in a situation conducive for VTE, 40% of participants were low risk, 22% were moderate risk, 21% were high risk, and 17% were very high risk. On a venous QOL assessment, 17% had a combined total score for all 11 questions of "very limited" or "impossible to do." Reflux or obstruction was noted in 37% and 5% of participants, respectively. CEAP class 0 to 6 was 29%, 29%, 23%, 10%, 9%, 1.5%, 0.5%, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease.}},
author = {{McLafferty, Robert B. and Passman, Marc A. and Caprini, Joseph A. and Rooke, Thom W. and Markwell, Steven A. and Lohr, Joanne M. and Meissner, Mark H. and Eklof, Bo G. and Wakefield, Thomas W. and Dalsing, Michael C.}},
issn = {{1097-6809}},
language = {{eng}},
number = {{2}},
pages = {{394--399}},
publisher = {{Mosby-Elsevier}},
series = {{Journal of Vascular Surgery}},
title = {{Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program}},
url = {{http://dx.doi.org/10.1016/j.jvs.2008.03.041}},
doi = {{10.1016/j.jvs.2008.03.041}},
volume = {{48}},
year = {{2008}},
}